Growth Factor Injections can Aid in the Proper Growth of the Fetus

The complications that arise because of the fetal growth restriction can be potentially lessened with the aid of growth factor injections.

The case of fetal growth restriction gives rise to many complications. These complications can be potentially solved with the aid of growth factor injections, reveals a study published in The Journal of Physiology.

Sheep fetuses received weekly injections of a growth factor (IGF1). There is always a risk that the increased demands of the larger fetus will not be met by the placenta during periods of stress, such as labor. However, the increased fetal growth did not increase the number of stillbirths and deaths in the period leading up to birth and in the first week after birth (also known as perinatal mortality).

Novel Biomaterial Offers Viable Alternative to Open Fetal Repair for Spina Bifida
Bioengineering an alternative to open fetal repair for spina bifida. The in utero application of the biomaterial was technically feasible and did not harm fetuses.

‘The usage of growth factor injections, could bring down the complications arising out of the case where, babies are being born small due to fetal growth restriction.’

The treatment may need to be modified according to the sex of the fetus, as the growth response after birth is sex-specific.

A placental hormone in the mother's blood (called NT-proCNP) was found to correlate with the level of oxygen the fetus received, which is a key indicator of fetal well-being.

Currently, oxygen levels can only be measured by methods that put the fetus at risk. This finding could mean the placental hormone could be used as test of fetal well-being, if future clinical trials prove its safety and efficacy in humans.

Study: Extreme Abnormal Fetal Growth Linked to Autism Risk
A new study has revealed that babies whose growth is at either extreme in the womb, either very small or very large, are at greater risk of developing autism.

This study, conducted by researchers at the University of Auckland-based Liggins Institute and the University of Otago, New Zealand, is the first to ever follow fetuses treated for fetal growth restriction during labor up into adulthood. It is important to now test whether the same effects are observed in humans.

Professor Frank Bloomfield, the lead investigator of the study and director of the Liggins Institute, said "Further adult hormonal and growth statuses in these animals will provide critical information on the effect of this treatment through to adulthood, providing further evidence of any long-term effects. The next step will then be studies in human pregnancies at greatest risk."

Tightening Up of Criteria for Definition of Intrauterine Growth Restriction Suggested By Study
The practice of using an arbitrary Estimated Fetal Weight (EFW) less than the 10th centile may not be an efficient practice for defining true Intrauterine Growth Restriction (IUGR).

Source-Eurekalert

Mother�s Arthritis - Risk for Chronic Disease in Offspring
Rheumatoid arthritis during pregnancy may increase chronic disease risk in children. Fetal exposure to maternal rheumatoid arthritis (RA) increases risk.